...
首页> 外文期刊>Life sciences >Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix
【24h】

Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix

机译:在人子宫子宫颈癌中表征甲基化调控miRNA

获取原文
获取原文并翻译 | 示例

摘要

Gene regulatory mechanisms determine the multistep carcinogenesis process. Two aspects of epigenetics are microRNA (miRNAs) and DNA methylation that regulate distinct biological mechanisms such as metastasis, apoptosis cell proliferation and induction of senescence. Although critical, the interplay between these two epigenetic mechanisms is yet to be completely understood, particularly in cervical cancer. To study the DNA methylation regulation of miRNAs and its potential role in cervical cancer, we investigated the differential methylation pattern of two candidate miRNAs (miR-375 and miR-196a-1) during cervical cancer progression against normal cervical epithelium (NCE) by bisulfite DNA sequencing. miR-375 and miR-196a-1 were hypermethylated in Squamous Cell Carcinoma (SCC) against NCE and Cervical Intra-Epithelial Neoplasia (CIN) (p < 0.05). Treatment with demethylating agent reactivated the miR-375 and miR-196a-1 expression in SiHa, HeLa and CaSki cells. In vitro artificial methylation by M.SssI followed by dual luciferase assay confirmed miR-375 and miR-196a-1 as methylation regulated miRNAs (P < 0.05). miR-375 and miR-196a-1 expression levels were negatively correlated with methylation levels in clinical specimens. We further identified Replication Factor C Subunit 3 (RFC3) and High Mobility Group AT-Hook 1 (HMGA1) as targets of miR-375 and miR-196a-1 respectively by dual luciferase reporter assay. Our analysis indicates that miR-375 and miR-196a-1 are DNA methylation regulated miRNAs whose deregulation may facilitate pathophysiology of cervical cancer.
机译:基因调节机制决定了多学期致癌过程。表观遗传学的两个方面是MicroRNA(miRNA)和DNA甲基化,其调节不同的生物机制,例如转移,凋亡细胞增殖和衰老诱导。虽然至关重要,但这两个表观遗传机制之间的相互作用尚未完全理解,特别是在宫颈癌中。为了研究MiRNA的DNA甲基化调节及其在宫颈癌中的潜在作用,我们通过亚硫酸氢盐对颈癌进展进行了两种候选miRNA(miR-375和miR-196a-1)的差异甲基化模式DNA测序。 miR-375和miR-196a-1在鳞状细胞癌(SCC)中对NCE和宫颈内上皮内肿瘤(CIN)的鳞状细胞癌(SCC)进行过甲基化(P <0.05)。用去甲基化试剂处理重新激活了Siha,Hela和Caski细胞中的miR-375和miR-196a-1表达。通过M.SssI体外人工甲基化,随后双重荧光素酶分析证实的miR-375和miR-196A-1作为甲基化调节的miRNA(P <0.05)。 miR-375和miR-196a-1表达水平与临床标本中的甲基化水平负相关。我们将通过双荧光素酶报告酶报告分析进一步将复制因子C亚基3(RFC3)和高迁移率组和高迁移率组和钩1(HMGA1)作为MIR-375和MIR-196A-1的靶标。我们的分析表明miR-375和miR-196a-1是DNA甲基化调节的miRNA,其放松剂可以促进宫颈癌的病理生理学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号